title: Lectin-induced differentiation of transformed neuroretinal cells in vitro.
abstract: The orderly course of chick neuroretinal cell differentiation was disrupted in vitro by infection with a temperature-sensitive strain of the Rous sarcoma virus (LA29). The resulting cell culture LA29NR remained mitotically active at 42 degrees C, yet rapidly adopted a transformed phenotype upon activation of the pp60v-src oncogene product at 37 degrees C. As a further indication of metabolic state, LA29NR cells expressed the protooncogene product c-Fos, as shown by Western blot analysis. Highly proliferative LA29NR cells proved refractory to standard differentiation agents such as cAMP, and prostaglandin E1. In our novel approach, succinylated concanavalin A (SCA), a nontoxic derivative of the lectin concanavalin A, induced dramatic, reversible morphological changes in LA29NR cells, including neurite outgrowth and increased cell-to-cell adhesion. Fluoresceinated SCA appeared to localize to Golgi and lysosomal structures. Cellular response to SCA treatment included decreased growth rate, reversible decrease in the phosphorylation state of a 41-kDa phosphoprotein, and induction of neuron-specific enolase. The glial marker vimentin was also evident in these cultures. These data suggest that SCA is an effective differentiation agent for cells of neuroectodermal origin, permitting neuronal as well as glial phenotypic expression within these cell populations.
authors.affiliation: Department of Neurobiology and Anatomy, University of Rochester Medical Center, New York 14642.
authors.forename: G M
authors.initials: GM
authors.lastname: Seigel
authors.forename: M F
authors.initials: MF
authors.lastname: Notter
mesh_terms: D000527:Alprostadil / Q000494:pharmacology; D000818:Animals; D001358:Avian Sarcoma Viruses; D015153:Blotting, Western; D002454:Cell Differentiation / Q000187:drug effects*; D002472:Cell Transformation, Viral; D002642:Chick Embryo; D003208:Concanavalin A / Q000378:metabolism / Q000494:pharmacology*; D000242:Cyclic AMP / Q000494:pharmacology; D007150:Immunohistochemistry; D008938:Mitosis; D016501:Neurites / Q000378:metabolism; D010751:Phosphopyruvate Hydratase / Q000378:metabolism; D010766:Phosphorylation; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D012160:Retina / Q000166:cytology* / Q000378:metabolism; D014443:Tyrosine / Q000378:metabolism; D014746:Vimentin / Q000378:metabolism
chemical_list: D016760:Proto-Oncogene Proteins c-fos; D014746:Vimentin; D003208:Concanavalin A; D014443:Tyrosine; C019558:succinylconcanavalin A; D000242:Cyclic AMP; D010751:Phosphopyruvate Hydratase; D000527:Alprostadil